ALDH1A1 as a molecular marker with better prognosis for glioblastoma patients

O. Schnell, S.A. Adam, S. Eigenbrod, H.A. Kretzschmar, J.C. Tonn & U. Schüller
Objective: Aldehyde dehydrogenase 1A1 (ALDH1A1) has been identified in a variety of human cancers to be expressed by tumor cells and to serve as a reliable marker to predict patients clinical outcome. However, little is known so far about the function of ALDH1A1 in malignant brain tumors. Methods:[for full text, please go to the a.m. URL]